EP2296692A4 - Isoform-specific insulin analogues - Google Patents
Isoform-specific insulin analoguesInfo
- Publication number
- EP2296692A4 EP2296692A4 EP09734135A EP09734135A EP2296692A4 EP 2296692 A4 EP2296692 A4 EP 2296692A4 EP 09734135 A EP09734135 A EP 09734135A EP 09734135 A EP09734135 A EP 09734135A EP 2296692 A4 EP2296692 A4 EP 2296692A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- isoform
- insulin analogues
- specific insulin
- specific
- analogues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4698508P | 2008-04-22 | 2008-04-22 | |
PCT/US2009/041439 WO2009132129A2 (en) | 2008-04-22 | 2009-04-22 | Isoform-specific insulin analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2296692A2 EP2296692A2 (en) | 2011-03-23 |
EP2296692A4 true EP2296692A4 (en) | 2012-06-06 |
Family
ID=41217411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09734135A Withdrawn EP2296692A4 (en) | 2008-04-22 | 2009-04-22 | Isoform-specific insulin analogues |
Country Status (12)
Country | Link |
---|---|
US (1) | US20110195896A1 (en) |
EP (1) | EP2296692A4 (en) |
JP (1) | JP2011521621A (en) |
KR (1) | KR20110021758A (en) |
CN (1) | CN102065885A (en) |
AU (1) | AU2009240636A1 (en) |
BR (1) | BRPI0911571A2 (en) |
CA (1) | CA2722168A1 (en) |
MX (1) | MX2010011329A (en) |
NZ (1) | NZ588857A (en) |
RU (1) | RU2010147076A (en) |
WO (1) | WO2009132129A2 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007081824A2 (en) | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
EP2074140B8 (en) | 2006-10-04 | 2015-10-28 | Case Western Reserve University | Fibrillation-resistant insulin and insulin analogues |
WO2009129250A2 (en) | 2008-04-14 | 2009-10-22 | Case Western Reserve University | Meal-time insulin analogues of enhanced stability |
US9200053B2 (en) | 2008-07-31 | 2015-12-01 | Case Western Reserve University | Insulin analogues containing penta-fluoro-Phenylalanine at position B24 |
KR20120129875A (en) * | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | Insulin analogues with chlorinated amino acids |
WO2011072288A2 (en) | 2009-12-11 | 2011-06-16 | Case Western Reserve University | Insulin analogues with chlorinated amino acids |
CA2747197A1 (en) | 2008-12-15 | 2010-06-24 | Zealand Pharma A/S | Glucagon analogues |
MA32970B1 (en) | 2008-12-15 | 2012-01-02 | Zealand Pharma As | Isotope glucagon |
EP2370460B1 (en) | 2008-12-15 | 2014-04-30 | Zealand Pharma A/S | Glucagon analogues |
CN102282166B (en) | 2008-12-15 | 2015-04-01 | 西兰制药公司 | Glucagon analogues |
UA104766C2 (en) | 2009-07-13 | 2014-03-11 | Зіленд Фарма А/С | Acylated glucagon analogues |
US20120184488A1 (en) * | 2009-09-01 | 2012-07-19 | Case Western Reserve University | Insulin analogues of enhanced receptor-binding specificity |
US8399407B2 (en) | 2009-09-17 | 2013-03-19 | Case Western Reserve University | Non-standard insulin analogues |
UY33462A (en) | 2010-06-23 | 2012-01-31 | Zealand Pharma As | GLUCAGON ANALOGS |
CN103068841A (en) | 2010-06-24 | 2013-04-24 | 西兰制药公司 | Glucagon analogues |
WO2012098462A1 (en) | 2011-01-20 | 2012-07-26 | Zealand Pharma A/S | Combination of acylated glucagon analogues with insulin analogues |
US10995129B2 (en) * | 2011-07-13 | 2021-05-04 | Case Western Reserve University | Non-standard insulin analogues |
NZ702333A (en) | 2012-05-03 | 2017-06-30 | Zealand Pharma As | Gip-glp-1 dual agonist compounds and methods |
MX356957B (en) | 2012-07-23 | 2018-06-20 | Zealand Pharma As | Glucagon analogues. |
TWI608013B (en) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | Glucagon analogues |
JP6584953B2 (en) * | 2012-11-05 | 2019-10-02 | ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University | Long-acting single-chain insulin analogue |
US9707276B2 (en) | 2012-12-03 | 2017-07-18 | Merck Sharp & Dohme Corp. | O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues |
JP2016516728A (en) * | 2013-03-15 | 2016-06-09 | ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University | Second site insulin analogue |
TW201605470A (en) | 2013-10-04 | 2016-02-16 | 默沙東藥廠 | Glucose-responsive insulin conjugates |
SG11201602965WA (en) | 2013-10-17 | 2016-05-30 | Zealand Pharma As | Acylated glucagon analogues |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
CN105849122B (en) | 2013-11-06 | 2021-04-30 | 西兰制药公司 | GIP-GLP-1 dual agonist compounds and methods |
TR201902516T4 (en) | 2013-11-06 | 2019-03-21 | Zealand Pharma As | Glucagon-glp-1-envy triple agonist compounds. |
US9901622B2 (en) | 2014-01-13 | 2018-02-27 | Thermalin Diabetes, Inc. | Rapid action insulin formulations and pharmaceutical delivery systems |
KR102569743B1 (en) | 2014-10-06 | 2023-08-23 | 케이스 웨스턴 리저브 유니버시티 | Biphasic Single-Chain Insulin Analogues |
EP3212218B1 (en) | 2014-10-29 | 2021-06-30 | Zealand Pharma A/S | Gip agonist compounds and methods |
CN108064173B (en) | 2014-11-21 | 2021-05-18 | 默沙东公司 | Partial insulin receptor agonists |
CN107636010B (en) | 2015-04-16 | 2021-10-01 | 西兰制药公司 | Acylated glucagon analogues |
AR105616A1 (en) | 2015-05-07 | 2017-10-25 | Lilly Co Eli | FUSION PROTEINS |
UY36870A (en) * | 2015-08-28 | 2017-03-31 | Hanmi Pharm Ind Co Ltd | NEW INSULIN ANALOGS |
WO2017040363A1 (en) | 2015-09-02 | 2017-03-09 | Merck Sharp & Dohme Corp. | A process for obtaining insulin with correctly formed disulfide bonds |
CN108348581B (en) | 2015-09-04 | 2022-07-01 | 斯克利普斯研究所 | Insulin immunoglobulin fusion proteins |
US11583572B2 (en) * | 2015-12-23 | 2023-02-21 | Case Western Reserve University | Encapsulation of ultra-stable insulin analogues with polymer melts |
EP3448417A4 (en) | 2016-04-26 | 2019-12-11 | Merck Sharp & Dohme Corp. | Insulin dimer-incretin conjugates |
EP3463429A4 (en) | 2016-05-24 | 2020-07-22 | Merck Sharp & Dohme Corp. | Insulin receptor partial agonists and glp-1 analogues |
US10689430B2 (en) | 2016-05-25 | 2020-06-23 | Merck Sharp & Dohme Corp. | Insulin receptor partial agonists |
WO2017210077A1 (en) * | 2016-06-02 | 2017-12-07 | Indiana University Research And Technology Corporation | Single chain insulin prodrugs |
WO2018015330A1 (en) | 2016-07-18 | 2018-01-25 | Eth Zurich | B-cell-mimetic cells |
EP3272877A1 (en) | 2016-07-18 | 2018-01-24 | ETH Zurich | B-cell-mimetic cells |
AR110193A1 (en) * | 2016-11-21 | 2019-03-06 | Univ Case Western Reserve | INSULIN ANALOGS OF FAST STABILITY IMPROVED ACTION |
US11041009B2 (en) | 2017-03-23 | 2021-06-22 | Merck Sharp & Dohme Corp. | Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes |
CN114591417B (en) * | 2022-04-22 | 2023-04-25 | 四川大学 | Human single chain insulin analogues and uses thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007081824A2 (en) * | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
WO2008043033A2 (en) * | 2006-10-04 | 2008-04-10 | Case Western Reserve University | Fibrillation-resistant insulin and insulin analogues |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
US5149777A (en) * | 1988-07-20 | 1992-09-22 | Novo Nordisk A/S | Human insulin analogs and preparations containing them |
US5716927A (en) * | 1988-12-23 | 1998-02-10 | Novo Nordisk A/S | Insulin analogs having a modified B-chain |
DE3844211A1 (en) * | 1988-12-29 | 1990-07-05 | Hoechst Ag | NEW INSULINE DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM |
US5514646A (en) * | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
DE3936876A1 (en) * | 1989-11-06 | 1991-05-23 | Hoechst Ag | NEW INSULINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THE SAME |
CZ342492A3 (en) * | 1991-11-26 | 1993-06-16 | Lilly Co Eli | Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised |
US6011007A (en) * | 1993-09-17 | 2000-01-04 | Novo Nordisk A/S | Acylated insulin |
US20030104981A1 (en) * | 1995-11-03 | 2003-06-05 | Jelena Mandic | Human insulin analogues |
DE19652713C2 (en) * | 1996-12-18 | 2001-11-22 | Aventis Pharma Gmbh | Process for the purification of insulin and insulin derivatives by chromatography on a strongly acidic cation exchanger |
DE19726167B4 (en) * | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, process for its preparation and pharmaceutical preparation containing it |
BR9813111A (en) * | 1997-10-24 | 2000-08-15 | Lilly Co Eli | Insoluble insulin compositions |
US6531448B1 (en) * | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
US7449443B2 (en) * | 2000-03-23 | 2008-11-11 | California Institute Of Technology | Method for stabilization of proteins using non-natural amino acids |
US7316999B2 (en) * | 2000-06-02 | 2008-01-08 | Novo Nordisk A/S | Glucose dependent release of insulin from glucose sensing insulin derivatives |
KR100449454B1 (en) * | 2000-10-02 | 2004-09-21 | 이현철 | Vector for Curing Diabetes Mellitus Containing Gene of Single-chain Insulin Analog |
WO2003053460A1 (en) * | 2001-12-19 | 2003-07-03 | Eli Lilly And Company | Crystalline compositions for controlling blood glucose |
US20050014679A1 (en) * | 2001-12-20 | 2005-01-20 | Beals John Michael | Insulin molecule having protracted time action |
AU2003226619A1 (en) * | 2002-03-26 | 2003-10-08 | Council Of Scientific And Industrial Research | An adipocyte insulin and a method of treating diabetes |
WO2003093299A2 (en) * | 2002-05-06 | 2003-11-13 | Thomas Jefferson University | Insulin-associated peptides with effects on cerebral health |
CA2518776A1 (en) * | 2003-04-29 | 2004-11-11 | Eli Lilly And Company | Insulin analogs having protracted time action |
CN1836047B (en) * | 2003-06-17 | 2010-12-22 | 赛姆生物***遗传公司 | Methods for the production of insulin in plants |
EP1692168B1 (en) * | 2003-12-03 | 2011-07-20 | Novo Nordisk A/S | Single-chain insulin |
US7790677B2 (en) * | 2006-12-13 | 2010-09-07 | Elona Biotechnologies | Insulin production methods and pro-insulin constructs |
RU2524423C2 (en) * | 2008-01-09 | 2014-07-27 | Санофи-Авентис Дойчланд Гмбх | Novel insulin derivatives with extremely delayed time/action profile |
WO2009129250A2 (en) * | 2008-04-14 | 2009-10-22 | Case Western Reserve University | Meal-time insulin analogues of enhanced stability |
KR20120129875A (en) * | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | Insulin analogues with chlorinated amino acids |
US8399407B2 (en) * | 2009-09-17 | 2013-03-19 | Case Western Reserve University | Non-standard insulin analogues |
US20110103575A1 (en) * | 2009-10-30 | 2011-05-05 | Telect Inc. | High-density splitter/patch telecommunications system |
-
2009
- 2009-04-22 BR BRPI0911571A patent/BRPI0911571A2/en not_active IP Right Cessation
- 2009-04-22 WO PCT/US2009/041439 patent/WO2009132129A2/en active Application Filing
- 2009-04-22 AU AU2009240636A patent/AU2009240636A1/en not_active Abandoned
- 2009-04-22 CN CN2009801244782A patent/CN102065885A/en active Pending
- 2009-04-22 US US12/989,399 patent/US20110195896A1/en not_active Abandoned
- 2009-04-22 CA CA2722168A patent/CA2722168A1/en not_active Abandoned
- 2009-04-22 EP EP09734135A patent/EP2296692A4/en not_active Withdrawn
- 2009-04-22 RU RU2010147076/10A patent/RU2010147076A/en not_active Application Discontinuation
- 2009-04-22 KR KR1020107025017A patent/KR20110021758A/en not_active Application Discontinuation
- 2009-04-22 JP JP2011506432A patent/JP2011521621A/en active Pending
- 2009-04-22 NZ NZ588857A patent/NZ588857A/en not_active IP Right Cessation
- 2009-04-22 MX MX2010011329A patent/MX2010011329A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007081824A2 (en) * | 2006-01-06 | 2007-07-19 | Case Western Reserve University | Fibrillation resistant proteins |
WO2008043033A2 (en) * | 2006-10-04 | 2008-04-10 | Case Western Reserve University | Fibrillation-resistant insulin and insulin analogues |
Also Published As
Publication number | Publication date |
---|---|
NZ588857A (en) | 2012-07-27 |
CA2722168A1 (en) | 2009-10-29 |
EP2296692A2 (en) | 2011-03-23 |
KR20110021758A (en) | 2011-03-04 |
US20110195896A1 (en) | 2011-08-11 |
CN102065885A (en) | 2011-05-18 |
JP2011521621A (en) | 2011-07-28 |
BRPI0911571A2 (en) | 2018-04-03 |
MX2010011329A (en) | 2011-03-15 |
RU2010147076A (en) | 2012-05-27 |
WO2009132129A3 (en) | 2010-01-21 |
AU2009240636A1 (en) | 2009-10-29 |
WO2009132129A2 (en) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2296692A4 (en) | Isoform-specific insulin analogues | |
HK1203531A1 (en) | Glucagon analogues | |
HK1161275A1 (en) | Halogen-stabilized insulin | |
EP2376520A4 (en) | Insulin analogs | |
ZA201006126B (en) | Protease stabilized, acylated insulin analogues | |
ZA201104592B (en) | Glucagon analogues | |
ZA201104593B (en) | Glucagon analogues | |
ZA201104591B (en) | Glucagon analogues | |
ZA201007843B (en) | Structured coauthoring | |
GB0823693D0 (en) | Autoinjector | |
PL2254624T3 (en) | Auto-injector | |
ZA201106755B (en) | Fast-acting insulin formulation | |
EP2291720A4 (en) | Sleep processor | |
HK1146064A1 (en) | Oxytocin analogues | |
GB201015431D0 (en) | Diffusion-cooled CO²laser with flexible housing | |
GB0901924D0 (en) | Imprived autoinjector | |
EP2576612A4 (en) | Insulin analogues | |
PL2323843T3 (en) | Surface portion | |
HK1157690A1 (en) | Syringe | |
GB0812019D0 (en) | Insulin | |
HK1156630A1 (en) | Schweinfurthin analogues schweinfurthin | |
ZA201104724B (en) | Improved bolus | |
GB0810230D0 (en) | Syringe arrangement | |
GB0809708D0 (en) | Microsoft x-runner | |
GB0807271D0 (en) | Syringes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20101119 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20120507 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 38/28 20060101AFI20120427BHEP |
|
17Q | First examination report despatched |
Effective date: 20130207 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20130418 |